BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 16959833)

  • 1. GPR39 signaling is stimulated by zinc ions but not by obestatin.
    Holst B; Egerod KL; Schild E; Vickers SP; Cheetham S; Gerlach LO; Storjohann L; Stidsen CE; Jones R; Beck-Sickinger AG; Schwartz TW
    Endocrinology; 2007 Jan; 148(1):13-20. PubMed ID: 16959833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake".
    Chartrel N; Alvear-Perez R; Leprince J; Iturrioz X; Reaux-Le Goazigo A; Audinot V; Chomarat P; Coge F; Nosjean O; Rodriguez M; Galizzi JP; Boutin JA; Vaudry H; Llorens-Cortes C
    Science; 2007 Feb; 315(5813):766; author reply 766. PubMed ID: 17289961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obestatin does not activate orphan G protein-coupled receptor GPR39.
    Lauwers E; Landuyt B; Arckens L; Schoofs L; Luyten W
    Biochem Biophys Res Commun; 2006 Dec; 351(1):21-5. PubMed ID: 17054911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39.
    Tremblay F; Perreault M; Klaman LD; Tobin JF; Smith E; Gimeno RE
    Endocrinology; 2007 Feb; 148(2):501-6. PubMed ID: 17095592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)?
    Gourcerol G; St-Pierre DH; Taché Y
    Regul Pept; 2007 Jun; 141(1-3):1-7. PubMed ID: 17321609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in obestatin gene and GPR39 receptor expression in peripheral tissues of rat models of obesity, type 1 and type 2 diabetes.
    Kolodziejski PA; Pruszynska-Oszmalek E; Sassek M; Kaczmarek P; Szczepankiewicz D; Billert M; Mackowiak P; Strowski MZ; Nowak KW
    J Diabetes; 2017 Apr; 9(4):353-361. PubMed ID: 27106635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake.
    Zhang JV; Ren PG; Avsian-Kretchmer O; Luo CW; Rauch R; Klein C; Hsueh AJ
    Science; 2005 Nov; 310(5750):996-9. PubMed ID: 16284174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of obestatin on energy balance and growth hormone secretion in rodents.
    Nogueiras R; Pfluger P; Tovar S; Arnold M; Mitchell S; Morris A; Perez-Tilve D; Vázquez MJ; Wiedmer P; Castañeda TR; DiMarchi R; Tschöp M; Schurmann A; Joost HG; Williams LM; Langhans W; Diéguez C
    Endocrinology; 2007 Jan; 148(1):21-6. PubMed ID: 17008393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR39 receptor expression in the mouse brain.
    Jackson VR; Nothacker HP; Civelli O
    Neuroreport; 2006 May; 17(8):813-6. PubMed ID: 16708020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39.
    Zhang JV; Jahr H; Luo CW; Klein C; Van Kolen K; Ver Donck L; De A; Baart E; Li J; Moechars D; Hsueh AJ
    Mol Endocrinol; 2008 Jun; 22(6):1464-75. PubMed ID: 18337590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse.
    Moechars D; Depoortere I; Moreaux B; de Smet B; Goris I; Hoskens L; Daneels G; Kass S; Ver Donck L; Peeters T; Coulie B
    Gastroenterology; 2006 Oct; 131(4):1131-41. PubMed ID: 17030183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist.
    Holst B; Cygankiewicz A; Jensen TH; Ankersen M; Schwartz TW
    Mol Endocrinol; 2003 Nov; 17(11):2201-10. PubMed ID: 12907757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common structural basis for constitutive activity of the ghrelin receptor family.
    Holst B; Holliday ND; Bach A; Elling CE; Cox HM; Schwartz TW
    J Biol Chem; 2004 Dec; 279(51):53806-17. PubMed ID: 15383539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin and obestatin: different role in fetal lung development?
    Nunes S; Nogueira-Silva C; Dias E; Moura RS; Correia-Pinto J
    Peptides; 2008 Dec; 29(12):2150-8. PubMed ID: 18789988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase inhibitor β enhances the constitutive activity of G-protein-coupled zinc receptor GPR39.
    Kovacs Z; Schacht T; Herrmann AK; Albrecht P; Lefkimmiatis K; Methner A
    Biochem J; 2014 Aug; 462(1):125-32. PubMed ID: 24869658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR39-1b, the 5-transmembrane isoform of GPR39 interacts with neurotensin receptor NTSR1 and modifies its function.
    Yasuda S; Ishida J
    J Recept Signal Transduct Res; 2014 Aug; 34(4):307-12. PubMed ID: 24512471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling.
    Holst B; Brandt E; Bach A; Heding A; Schwartz TW
    Mol Endocrinol; 2005 Sep; 19(9):2400-11. PubMed ID: 15905359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho kinase-dependent desensitization of GPR39; a unique mechanism of GPCR downregulation.
    Shimizu Y; Koyama R; Kawamoto T
    Biochem Pharmacol; 2017 Sep; 140():105-114. PubMed ID: 28619258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function.
    Granata R; Settanni F; Gallo D; Trovato L; Biancone L; Cantaluppi V; Nano R; Annunziata M; Campiglia P; Arnoletti E; Ghè C; Volante M; Papotti M; Muccioli G; Ghigo E
    Diabetes; 2008 Apr; 57(4):967-79. PubMed ID: 18162507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents.
    Zizzari P; Longchamps R; Epelbaum J; Bluet-Pajot MT
    Endocrinology; 2007 Apr; 148(4):1648-53. PubMed ID: 17204551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.